Edgewise Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues PTC Q1 2026 Earnings Strong EPS Beat Fuels Cautious Optimism Amid Slight Stock Dip AFLAC Q1 2026 Earnings EPS Misses Estimates Amid Operating Challenges SPOT Q1 2026 Earnings EPS Beats Estimates by 1445 as Stock Surges 611 OKTA Q1 2026 Earnings EPS Beat Drives Positive Market Reaction VALE Q1 2026 Earnings EPS Falls Short of Estimates Amid Commodity Market Headwinds